Deciphera Pharmaceuticals Investor Relations Material
Latest events
Q4 2023
Deciphera Pharmaceuticals
Q1 2024
10 May, 2024
Corporate Presentation
8 Feb, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Deciphera Pharmaceuticals Inc
Access all reports
Deciphera Pharmaceuticals Inc is a biopharmaceutical company focused on the development of kinase inhibitors to treat cancer. The company conducts clinical research and commercializes small-molecule therapies for solid tumors and hematologic malignancies. It is headquartered in Waltham, Massachusetts, and its shares are listed on the NASDAQ.
Latest articles
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
)
Nintendo: From Game Boy and Pokémon to Switch 2 and Mario Kart
Nintendo went from card maker to cultural icon, shaping modern entertainment through hardware innovation and world-famous characters.
19 Jun 2025
Ticker symbol
DCPH
Country
🇺🇸 United States